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Native and malondialdehyde modified low density lipoproteins have been shown to stimulate smooth muscle cell proliferation (A7r.5) in vitro. The 
stimulation is associated with an increase of protein kinase C activity. d-a-Tocopherol, at physiological concentrations, has been found to inhibit 
both protein kinase C activity and cell proliferation. 
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1. INTRODUCTION 
One of the major risk factors for cardiovascular dis- 
ease is hyperlipidemia, with elevated levels of choles- 
terol-rich low density lipoprotein (LDL). In combina- 
tion with other factors, high plasma concentrations of 
LDL promote the development of atherosclerosis [l]. 
Arterial smooth muscle cell migration, proliferation 
and metabolic changes contribute to the development of 
atherosclerotic lesions [2,3]. LDL stimulates cell prolif- 
eration in cultured human vascular smooth muscle cells 
[4,5] by phospholipase C-mediated phosphoinositide 
formation [6]. High density lipoprotein antagonise 
LDL-mediated stimulation of cell proliferation [5]. Oxi- 
datively modified LDL has been proposed to play a role 
in atherogenesis by inducing macrophage release of in- 
terleukin -lp, a mitogen for vascular smooth muscle 
cells, by inducing endothelial cell damage and by pro- 
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moting foam cell formation [7,8]. LDL-lipid peroxida- 
tion may be the cause of the structural and biological 
changes of human oxidised LDL [9]. Receptors for nor- 
mal and modified LDL exist on the macrophage cell 
membrane and other cells. Accumulation of modified 
LDL leads to the formation of foam cells, an integral 
part of the atherosclerotic picture [3]. An autocrine or 
paracrine platelet derived growth factor AA (PDGF 
AA) release and an induction of PDGF receptors are 
considered to be one of the mechanisms by which 
smooth muscle cells proliferate under the effect of LDL 
[lo]. d-a-Tocopherol is able to inhibit proliferation in 
a number of cell lines, including rat aorta smooth mus- 
cle (A7r5 and AlO), human aorta smooth muscle (HAI), 
mouse neuroblastoma (NB2A) and mouse fibroblast 
(Balb/3T3) but not in Chinese hamster ovary (LR73), 
human osteosarcoma (Saos-2) and mouse monocyte- 
macrophage (P388 Dl) [l 11. d-a-Tocopherol inhibition 
depends on the mitogen employed to induce cell prolif- 
eration being progressively bigger on going from lyso- 
phosphatidic acid to bombesin, fetal calf serum (FCS), 
PDGF-BB and endothelin [l 11. It has been shown that 
the effect of d-a-tocopherol is not related to its radical 
scavenging properties, but with its interaction with cell 
components, ultimately leading to inhibition of protein 
kinase C activity [12-151. In the present study, we have 
investigated the role of d-a-tocopherol in the prolifera- 
tion and protein kinase C activity of smooth muscle 
cells promoted by native and malondialdehyde modi- 
fied LDL. The data show that d-a-tocopherol inhibits 
vascular smooth muscle cell proliferation and protein 
kinase C activation produced by both types of LDL. 
The implications of this phenomenon, with respect to 
the protective effect of d-a-tocopherol against he onset 
of atherosclerosis as studied at an epidemiological level 
[16], will be discussed. 
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2. MATERIALS AND METHODS 
2. I. Materials 
Tissue culture materials were purchased from Falcon Labware 
(Becton Dickinson & Co) and growth media and serum for cell culture 
were obtained from Gibco Laboratories (Grand Island, NY, USA.). 
[y-“P]ATP (30 Ci/mmol) was from Amersham International. d-a- 
Tocopherol and d-@tocopherol were generous gifts from Hoffmann- 
La Roche & Co. (Basel, Switzerland). The peptide FKKSFKL (cus- 
tom synthesised by Dr. Rolli, Institut fiir Klinische Immunologie, 
Inselspital Bern, Switzerland) was used as a substrate for the PKC 
assay. Streptolysin 0 (25,000 units) and phorbol 12-myristate 13- 
acetate were from Sigma Chemical Company, St.Louis, MO. All other 
chemicals used were of the purest grade ~mmer~ially available. 
2.2. Cell culture 
The cell line used, A7r5 rat aortic smooth muscle cells (SMC), was 
obtained from American Type Culture Collection. Cells were grown 
in Dulbecco’s modified Eagle medium (DMEM) containing 25 mM 
sodium bicarbonate, 60 U/ml penicillin, 60 mg/ml streptomycin, and 
10% fetal calf serum (FCS). Cells were usually seeded into loo-mm 
plastic culture dishes and grown to confluence at 37°C in a humidified 
atmosphere of 5% CO2 (medium pH 7.4). Culture media were changed 
every 3 days. In all experiments, media and sera used were from the 
same batch number and source. 
2.3. Effect of d-a- and d-~-tocopherol oncell growth 
Tocopherols were added to the cell cultures according to the follow- 
ing procedure. Following 48 h serum-deprivation, cells were restimu- 
lated to growth by addition of LDL or 10% FCS in the presence or 
absence of the indicated tocopherols uspended in ethanolic solution. 
Cells were detached by t~psin~zation and counted in a hemo~ytometer 
in triplicate. Viability of the cells was assessed by the Trypan blue dye 
exclusion method. 
2.4. Preparation andmod~~cation ofhuman p~asn~a low density lipopro- 
teins 
LDL was prepared according to the method of Chung et al. [17]. 
Modified LDL was prepared by incubating 0.25 ml of 0.2 M malondi- 
aldehyde, generated by acid hydrolysis of malondialdehyde 
(bis(dimethy1 acetal)) Aldrich, with 0.5 ml of LDL (10 mg!ml) at 37°C 
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and pH 6.5 for 3 h [18]. Both native and modified LDL after 25 days 
at 04°C became unable to stimulate SMC proliferation (Ozer et al., 
unpublished) indicating that ageing of the LDL (presumably their 
oxidation) induced st~~tural changes resulting in loss of their cell 
growth stimulation property. Protein concentration was determined 
by using the kit by Pierce Co. 
2.5. Protein kinase C assay in permeabilized ceils 
Measurements of protein kinase C activity in permeabilised smooth 
muscle cells were performed according to the procedure of Alexander 
et al.[l9] with minor modifications. A7r.5 cells after 48 h serum depri- 
vation (G, phase) were preincubated for 7 h with LDL in the presence 
or absence of 50 FM d-~-tocopherol, and during the last 2 h in the 
presence (when specified) of 100 nM phorbol 12-myristate 13-acetate 
(PMA). Afterwards they were washed in phosphate-buffered saline 
(PBS), resuspended in intracellular buffer (5.2 mM MgCl,, 94 mM 
KC], 12.5 mM HEPES, 12.5 mM EGTA, 8.2 mM CaCI,, pH 7.4) and 
aliquoted in 220,& portions (1 .5x106 cells/ml). Assays were started by 
adding [y-“P]ATP (40 cpm/pmol, final concentration 250 PM), pep- 
tide substrate (final concentration 100 PM) and streptolysin-0 (0.6 
IX.). The reaction mixtures were incubated at 37°C for 5 min and the 
reaction was stopped by adding 100 ~1 of 25% (w/v) trichloroacetic 
acid in 2 M acetic acid. After being kept on ice for 10 min, samples 
were centrifuged for 10 min and spotted on P81 ion-exchange chrom- 
atography paper (Whatman International) which were then washed 
several times with 30% (v/v) acetic acid containing 1% (v/v) H,P04 and 
once with ethanol. The P81 papers were dried, and the bound radioac- 
tivity was counted in a liquid scintillation analyser. To estimate the 
background phosphorylation, assays were performed in the absence 
of substrate. The value of “P incorporated obtained in the latter 
condition has been subtracted from the experimental data to account 
for the specific activity. 
3. RESULTS AND DISCUSSION 
Incubation of smooth muscle cells in the presence of 
5 &ml LDL resulted in stimulation of cell growth (Fig. 
1A). No stimulation was observed when, together with 
LDL, also d-~-tocopherol (50 PM) was present in the 
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Fig. 1. Low density lipoprotein induced stimulation of smooth muscle cell proliferation. Cells (A7r5, rat aortic smooth muscle cells) were grown 
in DMEM containing 25 mM sodium bicarbonate, 60 U/ml penicillin, 60 mg/ml streptomycin, and 10% fetal calf serum (FCS) or 5 ,&ml LDL. 
d-a-Tocopherol(50pM) was added to the cell cultures after 48h serum-deprivation at the time when cells were restimulated to growth by addition 
of LDL or 10% FCS. Ceils were detached by t~psinization and counted in a hemocytometer. Viability of the ceils was assessed by the trypan blue 
dye exclusion method. Results are the mean f S.D. of three different experiments done in triplicate. 
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Fig. 2. Effect of d-a- and d-p-tocopherol on smooth muscle cell prolif- 
eration. The experimental conditions were similar to those described 
in the legend to Fig. 1. The concentration of d-/Stocopherol was 50 
PM. 
cell incubation medium, but no cytotoxic effects were 
detected. For comparison the growth promoting effect 
of FCS is also shown. In Fig. 1B is shown that also 
malondialdehyde-modified LDL induced cell growth, 
although to a lesser extent, but also in this case d-a- 
tocopherol (50 PM) was inhibitory. 
Fig. 2 compares the effect of d-a- and d-/?-tocophe- 
rols. The proliferation of SMC produced by modified 
LDL was more sensitive to d-a-tocopherol than to d-/I- 
tocopherol. Previously published data [13] have shown 
that d-a- and d-/?-tocopherol are taken up by smooth 
muscle cells in equal amounts, within experimental 
error. Thus a transport difference could not be respon- 
sible for the differential effects of d-a- and d-b-tocophe- 
rol. The distinct effects on cell proliferation of the 2 
tocopherols could only be associated with their differ- 
ences in molecular interactions since they possess very 
similar antioxidant and radical scavenger properties. 
The fact that both normal and modified LDL were able 
to stimulate cell proliferation under the experimental 
conditions employed in this study suggests that the lip- 
oprotein receptor as well as the scavenger eceptor can 
initiate a proliferative event. d-a-Tocopherol appears to 
act at some point in the cascade of events further lead- 
ing to activation of cell proliferation, Inhibition of pro- 
tein kinase C activity has been indicated to be a central 
event in the mechanism of cell growth inhibition by 
d-a-tocopherol[14,15]. Fig. 3 shows the effect of native 
and modified LDL on protein kinase C activity. Native 
and modified LDL stimulation of growth was linked to 
an increase of total protein kinase C activity of more 
than six-fold. With native LDL protein kinase C activity 
was present already in the absence of phorbol myristate 
acetate while with modified LDL the enzyme was in a 
state which required phorbol myristate acetate to show 
activity. 
Fig. 3 shows also the effect of d-a-tocopherol on 
protein kinase C activity. Both protein kinase C activity 
induced by native and modified LDL was d-a-tocophe- 
rol sensitive. The concentration which gave full inhibi- 
tion of smooth muscle cell protein kinase C (50,~M) was 
close to the human plasma (40 PM) d-a-tocopherol 
physiological concentration [161. 
4. CONCLUSIONS 
In the multifactorial pathogenesis of atherosclerosis, 
antioxidants, such as d-a-tocopherol, are supposed to 
play their role in preventing the oxidative modification 
of lipoproteins, their uptake and the consequent deposi- 
tion of fat in macrophages and smooth muscle cells. The 
picture appears to be more complex, due to the in- 
creased expression of PDGF-AA and of PDGF recep- 
tors produced in smooth muscle cells by LDL with con- 
sequent stimulation of cell proliferation [lo]. The inhibi- 
tion of protein kinase C and of SMC proliferation (in- 
duced by LDL) observed in this study suggests a new 
and additional role for d-a-tocopherol. d-a-Tocopherol 
would not only prevent the oxidation of lipoproteins, 
but it would also counterbalance the proliferative stim- 
ulus of LDL. Such a growth effect, possibly mediated 
by autocrine PDGF liberation, could be prevented by 
inhibiting protein kinase C, a central element in the 
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Fig. 3. Effect of d-a-tocopherol on native and modified low density 
lipoprotein stimulated protein kinase C activity. A7r5 cells in the late 
G, phase of the cycle, preincubated for 7 h in the presence of the 
indicated concentrations of LDL (5 &ml) and tocopherol (50 PM) 
(and when applicable for the last 2 h with 100 nM PMA), were washed 
and assayed for protein kinase C activity by adding [y-‘*P]ATP (40 
cpm/pmol, final concentration 250 PM), peptide substrate (final con- 
centration 100fiM) and streptolysin-0 (0.6 I.U.). After 10 min incuba- 
tion at 37°C the reaction was stopped by 100 ~1 of 25% (w/v) trichlo- 
roacetic acid and the samples centrifuged for 5 min and spotted on P81 
ion-exchange chromatography paper. The background phosphoryla- 
tion, measured in the absence of substrate, was subtracted. 
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